Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases - Université de Lorraine Access content directly
Journal Articles European Journal of Internal Medicine Year : 2021

Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases

Daniela Lakomy
Sabine Revuz
  • Function : Author
Fichier principal
Vignette du fichier
S0953620521001436.pdf (320.39 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03504774 , version 1 (16-10-2023)

Licence

Attribution - NonCommercial

Identifiers

Cite

Paul Decker, Thomas Moulinet, Benjamin Lopez, Sylvain Dubucquoi, Bernard Bonnotte, et al.. Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases. European Journal of Internal Medicine, 2021, 91, pp.45-52. ⟨10.1016/j.ejim.2021.04.020⟩. ⟨hal-03504774⟩
29 View
8 Download

Altmetric

Share

Gmail Facebook X LinkedIn More